| P2093 | author name string | X Jiang | |
| | J R Couchman | |
| | P Tapanadechopone | |
| | S Tumova | |
| P2860 | cites work | Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo | Q24564477 |
| | Perlecan maintains the integrity of cartilage and some basement membranes | Q24680954 |
| | Perlecan is essential for cartilage and cephalic development | Q28146148 |
| | Abnormal expression of perlecan proteoglycan in metastatic melanomas | Q28240180 |
| | A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells | Q28241050 |
| | Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate | Q28257965 |
| | The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans | Q28259215 |
| | The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases | Q28278296 |
| | Regulated diversity of heparan sulfate | Q28282444 |
| | Matrix proteoglycans: from molecular design to cellular function | Q28284300 |
| | Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells | Q28303061 |
| | Perlecan and basement membrane-chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix | Q28909753 |
| | Functions of cell surface heparan sulfate proteoglycans | Q29618521 |
| | Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. | Q34475404 |
| | The FGF family of growth factors and oncogenes | Q35335377 |
| | Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach | Q37461866 |
| | Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan | Q38317495 |
| | Proteoglycans and neoplasia | Q39653956 |
| | Altered proteoglycan gene expression and the tumor stroma | Q40910751 |
| | Expression and characterization of human perlecan domains I and II synthesized by baculovirus-infected insect cells | Q40922083 |
| | Structural comparison of fibroblast growth factor-specific heparan sulfates derived from a growing or differentiating neuroepithelial cell line | Q41041044 |
| | A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant | Q41153435 |
| | Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence | Q41381551 |
| | C-JUN/AP-1 as possible mediators of tumor necrosis factor-alpha-induced apoptotic response in mouse JB6 tumor cells | Q41385024 |
| | A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells. | Q41499345 |
| | Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential | Q41611327 |
| | Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid | Q41695436 |
| | Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis | Q42476789 |
| | Characterization of a dermatan sulfate proteoglycan synthesized by murine parietal yolk sac (PYS-2) cells | Q44018180 |
| | 12 Analysis of DNA-protein interactions by affinity coelectrophoresis | Q44510018 |
| | Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels | Q44528336 |
| | Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice | Q46431064 |
| | Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 |
| | Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. | Q53437765 |
| | Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma | Q59617854 |
| | Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion | Q64146688 |
| | Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid | Q70044668 |
| | Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin | Q70708108 |
| | Glycosaminoglycans of pleural mesothelioma: a possible biochemical variant containing chondroitin sulfate | Q71551712 |
| | Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue | Q71964407 |
| | Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis | Q73039097 |
| | Heparan sulphate proteoglycan expression in human primary liver tumours | Q77407102 |
| | Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx | Q77703639 |
| P433 | issue | Pt 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 517-527 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Epidermal transformation leads to increased perlecan synthesis with heparin-binding-growth-factor affinity | |
| P478 | volume | 355 | |